{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:39:22Z","timestamp":1790260762011,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1378\/chest.123.3.835","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"835-844","source":"Crossref","is-referenced-by-count":56,"title":["Variability in Antibiotic Prescribing Patterns and Outcomes in Patients With Clinically Suspected Ventilator-Associated Pneumoniaa"],"prefix":"10.1016","volume":"123","author":[{"given":"Robert A.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara E.","family":"Flavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann B.","family":"Weinacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Parsonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.123.3.835_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0891-5520(05)70364-0","article-title":"Nosocomial pneumonia: diagnosis and prevention","volume":"11","author":"Mayhall","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1378\/chest.123.3.835_bib2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/oxfordjournals.aje.a115245","article-title":"Hospital-acquired pneumonia: attributable mortality and morbidity","volume":"129","author":"Leu","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1378\/chest.123.3.835_bib3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","article-title":"Nosocomial infections in medical intensive care units in the United States","volume":"27","author":"Richards","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","article-title":"The prevalence of nosocomial infection in intensive care units in Europe: results of the European prevalence of infection in intensive care (EPIC) study; EPIC International Advisory Committee","volume":"274","author":"Vincent","year":"1995","journal-title":"JAMA"},{"key":"10.1378\/chest.123.3.835_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1164\/ajrccm.154.1.8680705","article-title":"Effect of ventilator-associated pneumonia on mortality and morbidity","volume":"154","author":"Papazian","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jama.1996.03530350048033","article-title":"Nosocomial pneumonia and mortality among patients in intensive care units","volume":"275","author":"Fagon","year":"1996","journal-title":"JAMA"},{"key":"10.1378\/chest.123.3.835_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1378\/chest.100.2.439","article-title":"Incidence etiology and outcome of nosocomial pneumonia in mechanically ventilated patients","volume":"100","author":"Rello","year":"1991","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinte.1988.00380050165024","article-title":"Nosocomial infection and fatality in medical and surgical intensive care unit patients","volume":"148","author":"Craven","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.123.3.835_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/ajrccm.159.4.9807050","article-title":"The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient","volume":"159","author":"Heyland","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-129-6-199809150-00002","article-title":"Incidence and risk factors for ventilator-associated pneumonia in critically ill patients","volume":"129","author":"Cook","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.3.835_bib11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.279.20.1605","article-title":"Risk factors for ICU-acquired pneumonia","volume":"279","author":"Cook","year":"1998","journal-title":"JAMA"},{"key":"10.1378\/chest.123.3.835_bib12","first-page":"1058","article-title":"","volume":"139","author":"CDC definitions for nosocomial infections","year":"1988","journal-title":"Am Rev Respir Dis 1989"},{"key":"10.1378\/chest.123.3.835_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1378\/chest.115.4.1076","article-title":"The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia","volume":"115","author":"Heyland","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-132-8-200004180-00004","article-title":"Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial","volume":"132","author":"Fagon","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.3.835_bib15","doi-asserted-by":"crossref","first-page":"177S","DOI":"10.1378\/chest.117.4_suppl_2.177S","article-title":"Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia: executive summary","volume":"117","author":"Grossman","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/516294","article-title":"Treatment of ventilator-associated pneumonia with piperacillin-tazobactam\/amikacin vs ceftazidime\/amikacin: a multicenter, randomized controlled trial; VAP Study Group","volume":"26","author":"Brun-Buisson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.123.3.835_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1378\/chest.115.1.8","article-title":"Antimicrobial therapy of ventilator-associated pneumonia: how to select an appropriate drug regimen","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib18","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1378\/chest.115.suppl_1.28S","article-title":"Nosocomial pneumonia in the ICU: year 2000 and beyond","volume":"115","author":"Bowton","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on therapy and outcome of ventilator-associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01712153","article-title":"Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group","volume":"22","author":"Alvarez-Lerma","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1378\/chest.123.3.835_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/ajrccm.156.1.9607030","article-title":"The value of routine microbial investigations in ventilator-associated pneumonia","volume":"156","author":"Rello","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1378\/chest.113.2.412","article-title":"The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator associated pneumonia","volume":"113","author":"Kollef","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1378\/chest.93.2.318","article-title":"Nosocomial pneumonia: a multivariate analysis of risk and prognosis","volume":"93","author":"Celis","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib24","doi-asserted-by":"crossref","first-page":"412S","DOI":"10.1378\/chest.119.2_suppl.412S","article-title":"Guidelines and critical pathways for severe hospital-acquired pneumonia","volume":"119","author":"Fiel","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib25","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1164\/ajrccm.158.6.9610069","article-title":"Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling","volume":"158","author":"George","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib26","first-page":"1711","article-title":"Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies; a consensus statement","volume":"153","author":"American Thoracic Society","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: A severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib28","first-page":"187","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1378\/chest.123.3.835_bib29","series-title":"Multivariable analysis: a practical guide for clinicians","first-page":"60","author":"Katz","year":"1999"},{"key":"10.1378\/chest.123.3.835_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib31","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AAC.42.11.2966","article-title":"A prospective randomized comparison of imipenem-cilastin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis","volume":"42","author":"Jaccard","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.123.3.835_bib32","first-page":"607","article-title":"A prospective, randomized, controlled trial of imipenem-cilastin vs cefotaxime-amikacin in the treatment of lower respiratory tract infections and septicaemia in intensive care units","volume":"19","author":"Mouton","year":"1990","journal-title":"Presse Med"},{"key":"10.1378\/chest.123.3.835_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/43.3.389","article-title":"Piperacillin\/tazobactam plus tobramycin vs ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection: Piperacillin\/Tazobactam Nosocomial Pneumonia Study Group","volume":"43","author":"Joshi","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.123.3.835_bib34","doi-asserted-by":"crossref","first-page":"SA9","DOI":"10.1093\/jac\/12.suppl_A.9","article-title":"A multicentre prospective randomized trial comparing ceftazidime with cefazolin\/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia","volume":"12","author":"Mandell","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1378\/chest.123.3.835_bib35","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1378\/chest.119.2_suppl.373S","article-title":"Hospital-acquired pneumonia: risk factors, microbiology, and treatment","volume":"119","author":"Lynch","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1378\/chest.101.4.1028","article-title":"Penetration of netilmicin in the lower respiratory tract after once-daily dosing","volume":"10","author":"Valcke","year":"1992","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1164\/ajrccm\/142.5.1099","article-title":"The penetration of aminoglycosides into the alveolar lining fluid of rats: the effect of airway inflammation","volume":"142","author":"Valcke","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.3.835_bib38","first-page":"208","article-title":"Bronchial secretion concentrations of tobramycin","volume":"125","author":"Alexander","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.3.835_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0009-9236(99)70103-7","article-title":"Tobramycin penetration into epithelial lining fluid of patients with pneumonia","volume":"65","author":"Carcas","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1378\/chest.123.3.835_bib40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.43.3.623","article-title":"Optimizing aminoglycoside therapy for nosocomial pneumonia caused by Gram-negative bacteria","volume":"43","author":"Kashuba","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.123.3.835_bib41","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9343(84)90358-9","article-title":"Association of aminoglycoside plasma levels with therapeutic outcome in Gram-negative pneumonia","volume":"77","author":"Moore","year":"1984","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.3.835_bib42","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.123.3.835_bib43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/AAC.38.3.547","article-title":"Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastin","volume":"38","author":"Fink","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.123.3.835_bib44","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.41.5.1127","article-title":"Monotherapy vs \u03b2-lactam-aminoglycoside combination treatment for Gram-negative bacteremia: a prospective, observational study","volume":"41","author":"Leibovici","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.123.3.835_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.109.4.1019","article-title":"Ventilator-associated pneumonia due toPseudomonas aeruginosa","volume":"109","author":"Crouch","year":"1996","journal-title":"Chest"},{"issue":"suppl 3","key":"10.1378\/chest.123.3.835_bib46","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1093\/clind\/21.Supplement_3.S226","article-title":"Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units","volume":"21","author":"Chastre","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.123.3.835_bib47","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0002-9343(89)80611-4","article-title":"Antibiotic therapy forPseudomonas aeruginosabacteremia: outcome correlations in a prospective study of 200 patients","volume":"87","author":"Hilf","year":"1989","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.3.835_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/ajrccm\/142.3.523","article-title":"Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients","volume":"142","author":"Torres","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.3.835_bib49","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00003246-200106000-00003","article-title":"Experience with a clinical guideline for the treatment of ventilator-associated pneumonia","volume":"29","author":"Ibrahim","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1378\/chest.123.3.835_bib50","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1378\/chest.117.4_suppl_2.195S","article-title":"Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia","volume":"117","author":"Cook","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib51","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1378\/chest.120.3.955","article-title":"International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia","volume":"120","author":"Rello","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.835_bib52","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.1993.03510160083034","article-title":"Ventilator-associated pneumonia: a multivariate analysis","volume":"270","author":"Kollef","year":"1993","journal-title":"JAMA"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216347535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216347535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T17:26:36Z","timestamp":1584811596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216347535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0012369216347535"],"URL":"https:\/\/doi.org\/10.1378\/chest.123.3.835","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}